1Elsevier items and derived items © 2007 by Saunders, an imprint of Elsevier, Inc. Chapter 33 Immunologic Disorders.
AT 4 Receptor Ligands as Angiogenic, Anti-angiogenic, and Anti-cancer Agents How do you translate basic science into a clinically useful technology?
AT 4 Receptor Ligands as Angiogenic, Anti-angiogenic, and Anti-cancer Agents
The Effects of Deleting Cytosolic Thioredoxin Reductase on p53 Target Gene Expression Sydney Radding Dr. Gary Merrill Dept. Of Biochemistry/Biophysics.
